- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06019494
Comparison of 2 Different Flow Rates During Oocyte Retrieval
Is Flow Rate During Oocyte Retrieval Associated With the Number of Oocytes Retrieved? A Randomized Control Trial
Study Overview
Status
Conditions
Detailed Description
In the current study, each ovary will be randomly allocated to oocyte retrieval using 0.42 ml/sec or 0.62 ml/sec flow rate.
The primary endpoint will be the number of oocytes retrieved, while secondary outcomes will include oocyte recovery rate (number of oocytes retrieved per follicle aspirated), number of mature oocytes, maturation rate (number of mature oocytes/number of oocytes retrieved), mean oocyte score (by evaluating oocyte shape and size, ooplasm characteristics, structure of perivitelline space (PVS), structure of zona pellucida (ZP) and polar body (PB) morphology), fertilization rate (number of fertilized oocytes/number of mature oocytes), number of blastocysts and blastulation rate (number of blastocysts/number of 2PN).
Patients aged 18-43 years with the presence of at least 3 follicles ≥ 11mm in each ovary on the day of oocyte retrieval will be eligible for inclusion in the study.
Prior to oocyte retrieval in eligible patients their left and right ovary will be randomly allocated into the 0.42 ml/sec or 0.62 ml/sec flow rate group. Randomisation with minimisation will be employed.
The specific flow rates will be achieved by adjusting the aspiration pressure of the vacuum pump accordingly. A study nurse will be responsible for adjusting the aspiration pressure of the vacuum pump depending on randomization. The doctor performing the oocyte retrieval will not be aware of the flow rate used in each ovary.
All follicles will be aspirated and then flushed if needed up to a maximum of 5 times with an open flushing technique, using a 16G double-lumen needle.
Data will be registered regarding the number of flushes required to retrieve a COC, the morphology of oocytes after denudation, oocyte fertilisation and embryo development up to the blastocyst stage.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Athens, Greece, 11528
- Eugonia Unit of Assisted Reproduction
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Presence of both ovaries
- 18-43 years old
- At least 3 follicles ≥ 11mm in each ovary on the day of oocyte retrieval
Exclusion Criteria:
- One or no ovaries present
- Monofollicular development
- Poor responders
- Previous history of hemorrhage during oocyte retrieval
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low aspiration flow rate
All follicles will be aspirated with the addition of follicular flushing if necessary with an aspiration flow rate of 0.42ml/sec.
|
All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle) with an aspiration flow rate of 0.42 ml/sec.
|
Experimental: High aspiration flow rate
All follicles will be aspirated with the addition of follicular flushing if necessary with an aspiration flow rate of 0.62ml/sec.
|
High aspiration flow rate All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle) with an aspiration flow rate of 0.62 ml/sec.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of oocytes retrieved
Time Frame: During oocyte retrieval
|
Number of oocytes retrieved per ovary randomised.
|
During oocyte retrieval
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oocyte recovery rate
Time Frame: During oocyte retrieval
|
Number of oocytes retrieved per follicle aspirated.
|
During oocyte retrieval
|
Oocyte maturation rate
Time Frame: 2-3 hours post oocyte retrieval
|
Number of mature (metaphase-II) oocytes divided by the number of oocytes retrieved per ovary randomised.
|
2-3 hours post oocyte retrieval
|
Fertilization rate
Time Frame: Day 1 post oocyte retrieval
|
Number of fertilised (2PN) oocytes divided by the number of matured oocytes retrieved per ovary randomised.
|
Day 1 post oocyte retrieval
|
Percentage of good quality blastocysts on day 5
Time Frame: 5 days post oocyte retrieval
|
Number of good quality blastocysts divided by the number of fertilized oocytes per ovary randomised.
|
5 days post oocyte retrieval
|
Average oocyte score
Time Frame: 2-3 hours post oocyte retrieval
|
Average oocyte score based on the evaluation of oocyte shape and size, ooplasm characteristics, structure of perivitelline space, structure of zona pellucida and polar body morphology.
|
2-3 hours post oocyte retrieval
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: George T Lainas, PhD, Eugonia ART Unit
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Flow rate for oocyte retrieval
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Oocyte retrieval with low aspiration flow rate
-
Istituto Clinico HumanitasCompleted
-
Tianjin Medical University General HospitalRecruiting
-
Iladevi Cataract and IOL Research CenterCompleted
-
Kahramanmaras Sutcu Imam UniversityCompletedLow Flow Anesthesia | Volatile Anesthetic ConsumptionTurkey
-
Beth Israel Deaconess Medical CenterWithdrawnAcute Respiratory Distress Syndrome | Low Tidal Volume VentilationUnited States
-
Universidade Federal do CearaNot yet recruiting
-
AspetarRecruitingPatellofemoral Pain Syndrome | Knee Pain Chronic | Rotator Cuff Tendinosis | Rotator Cuff Impingement Syndrome | Anterior Knee Pain SyndromeQatar
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
Institut für Pneumologie Hagen Ambrock eVTNI Medical AGCompleted
-
University of Colorado, DenverDavis Phinney FoundationRecruitingLow-load Resistance Training With Blood Flow Restriction in People With Parkinson's Disease (BFR-PD)Parkinson DiseaseUnited States